Gemini Therapeutics (GMTX) Short Interest Ratio & Short Volume → AI Bubble Now at Critical Mass (From Porter & Company) (Ad) Free GMTX Stock Alerts $60.51 +0.21 (+0.35%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media Gemini Therapeutics Short Interest DataCurrent Short Volume1,470,000 sharesPrevious Short Volume1,490,000 sharesChange Vs. Previous Month-1.34%Dollar Volume Sold Short$2.27 millionShort Interest Ratio / Days to Cover15.1Last Record DateDecember 15, 2022Outstanding Shares43,328,000 sharesFloat Size19,950,000 sharesShort Percent of Float7.37%Today's Trading Volume244,381 sharesAverage Trading Volume189,291 sharesToday's Volume Vs. Average129% Short Selling Gemini Therapeutics ? Sign up to receive the latest short interest report for Gemini Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGMTX Short Interest Over TimeGMTX Days to Cover Over TimeGMTX Percentage of Float Shorted Over Time Ad Porter & CompanyAI Bubble Now at Critical MassWashington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.Simply click here now to read The Big AI Die-Up. Gemini Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20221,470,000 shares $2.27 million -1.3%7.4%15.1 $1.55 11/30/20221,490,000 shares $2.56 million -1.3%7.5%14.2 $1.72 11/15/20221,510,000 shares $2.43 million +2.0%7.6%14.4 $1.61 10/31/20221,480,000 shares $2.66 million +4.2%7.3%10.7 $1.80 10/15/20221,420,000 shares $2.37 million No Change7.0%10.9 $1.67 9/30/20221,420,000 shares $2.33 million -6.0%7.0%12.7 $1.64 Get the Latest News and Ratings for GMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/20221,510,000 shares $2.13 million +5.6%7.5%9.6 $1.41 8/31/20221,430,000 shares $2.22 million -6.5%7.1%9.2 $1.55 8/15/20221,530,000 shares $2.85 million +7.0%7.6%9.2 $1.86 7/31/20221,430,000 shares $2.19 million No Change7.1%9.5 $1.53 7/15/20221,430,000 shares $2.23 million -7.1%7.1%8.9 $1.56 6/30/20221,540,000 shares $2.60 million -35.0%7.6%7.8 $1.69 6/15/20222,370,000 shares $3.51 million +0.4%11.7%10.4 $1.48 5/31/20222,360,000 shares $3.02 million +0.9%11.7%10.2 $1.28 5/15/20222,340,000 shares $3.30 million +7.3%11.6%7.6 $1.41 4/30/20222,180,000 shares $3.29 million -6.4%10.8%7.1 $1.51 4/15/20222,330,000 shares $3.61 million +13.1%11.5%7.5 $1.55 3/31/20222,060,000 shares $2.86 million -1.0%13.2%7 $1.39 3/15/20222,080,000 shares $2.97 million +7.8%13.4%6.5 $1.43 2/28/20221,930,000 shares $2.62 million +1.6%12.4%1.5 $1.36 2/15/20221,900,000 shares $3.36 million +5.6%12.2%1.6 $1.77 1/31/20221,800,000 shares $3.53 million -3.2%10.0%1.5 $1.96 1/15/20221,860,000 shares $3.94 million -8.4%9.6%1.6 $2.12 12/31/20212,030,000 shares $5.91 million +14.0%10.5%1.8 $2.91 12/15/20211,780,000 shares $5.32 million +1.7%9.2%1.6 $2.99 11/30/20211,750,000 shares $4.83 million No Change9.1%13.4 $2.76 11/15/20211,750,000 shares $6.27 million -3.3%9.1%9.5 $3.58 10/29/20211,810,000 shares $6.88 million +5.2%9.4%9 $3.80 10/15/20211,720,000 shares $6.40 million -2.8%8.9%7.8 $3.72 9/30/20211,770,000 shares $7.15 million -11.1%9.2%7.2 $4.04 9/15/20211,990,000 shares $8.97 million +5.3%10.3%5 $4.51 8/31/20211,890,000 shares $9.30 million -3.1%9.6%3.7 $4.92 8/13/20211,950,000 shares $7.94 million No Change9.9%4.2 $4.07 GMTX Short Interest - Frequently Asked Questions What is Gemini Therapeutics' current short interest? Short interest is the volume of Gemini Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 15th, traders have sold 1,470,000 shares of GMTX short. 7.37% of Gemini Therapeutics' shares are currently sold short. Learn More on Gemini Therapeutics' current short interest. What is a good short interest ratio for Gemini Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMTX shares currently have a short interest ratio of 15.0. Learn More on Gemini Therapeutics's short interest ratio. What is a good short interest percentage for Gemini Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.37% of Gemini Therapeutics' floating shares are currently sold short. Is Gemini Therapeutics' short interest increasing or decreasing? Gemini Therapeutics saw a drop in short interest in the month of December. As of December 15th, there was short interest totaling 1,470,000 shares, a drop of 1.3% from the previous total of 1,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Gemini Therapeutics' float size? Gemini Therapeutics currently has issued a total of 43,328,000 shares. Some of Gemini Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gemini Therapeutics currently has a public float of 19,950,000 shares. How does Gemini Therapeutics' short interest compare to its competitors? 7.37% of Gemini Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Gemini Therapeutics: Arvinas, Inc. (11.63%), Indivior PLC (0.13%), HUTCHMED (China) Limited (0.28%), ACADIA Pharmaceuticals Inc. (6.45%), MorphoSys AG (1.39%), Crinetics Pharmaceuticals, Inc. (7.20%), MoonLake Immunotherapeutics (14.83%), Merus (7.08%), Evotec SE (0.02%), IDEAYA Biosciences, Inc. (13.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.47 billion), Suncor Energy Inc. ($2.33 billion), T. Rowe Price Group, Inc. ($2.14 billion), PG&E Co. ($1.61 billion), Etsy, Inc. ($1.56 billion), Paramount Global ($1.53 billion), Old Dominion Freight Line, Inc. ($1.49 billion), Coinbase Global, Inc. ($1.46 billion), DICK'S Sporting Goods, Inc. ($1.30 billion), and C.H. Robinson Worldwide, Inc. ($1.26 billion). View all of the most shorted stocks. What does it mean to sell short Gemini Therapeutics stock? Short selling GMTX is an investing strategy that aims to generate trading profit from Gemini Therapeutics as its price is falling. GMTX shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gemini Therapeutics? A short squeeze for Gemini Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GMTX, which in turn drives the price of the stock up even further. How often is Gemini Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMTX, twice per month. The most recent reporting period available is December, 15 2022. More Short Interest Resources from MarketBeat Related Companies: ARVN Short Squeeze INDV Short Squeeze HCM Short Squeeze ACAD Short Squeeze MOR Short Squeeze CRNX Short Squeeze MLTX Short Squeeze MRUS Short Squeeze EVO Short Squeeze IDYA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GMTX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingFed launches fourth dollar overhaulStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy